COT Meeting: 8 April 2016

Last updated:
23 March 2016
Agenda and papers for the meeting of the Committee at 10.00am on Friday, 8th April 2016 in Conference Rooms 4 & 5, Aviation House, 125 Kingsway, London WC2 6NH

Agenda

1.  Apologies for absence

2.  Draft minutes of February meeting  TOX/MIN/2015/01

3.  Matters arising

4.  Follow-up paper on the submission for a reformulation of PAVA irritant spray - RESERVED BUSINESS  TOX/2016/10

5.  Review of risks arising from the infant diet and the development of atopic and autoimmune disease: Systematic review B – Timing of introduction of allergenic foods to the infant diet: a systematic review and meta-analysis - The committee will discuss the findings from this FSA-funded project. RESERVED BUSINESS   TOX/2016/11

6.  Review of potential risks from acrylamide in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. This is part of ongoing work in which the COT are reviewing the risks of toxicity from chemicals in the diets of infants and young children.  TOX/2016/12

7.  First draft statement on potential risks from arsenic in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. This draft COT statement summarises the available information and the Committee’s provisional conclusions. TOX/2016/13

8.  Second draft addendum to the 2013 COT statement on potential risks from lead in the infant diet. This draft COT statement summarises the available information and the Committee’s provisional conclusions. TOX/2016/14

9.  First draft addendum to the 2013 COT statement on potential risks from aluminium in the infant diet. This draft COT statement summarises the available information and the Committee’s provisional conclusions. TOX/2016/06

10.  Draft 2015 Annual Report. COT section of the 2015 Annual report for the Committees on Toxicity, Mutagenicity and Carcinogenicity. Members are invited to agree the text and also to consider how the COT has performed during 2015 against the Good Practice Guidelines for committees advising the Food Standards Agency (FSA). TOX/2016/09

11.  Peer review’ by EU-ANSA Agencies – a reflection paper. This EU-ANSA paper provides an opportunity to consider the extent to which COT statements would meet the key principles outlined and whether COT should adopt similar principles when asked to peer review unpublished research. TOX/2016/17

12.  Paper for Information - Update on actions taken subsequent to COT advice. TOX/2016/15

13.  Paper for information: FSA Scientific Advisory Committees (SACs) update. TOX/2016/16

14.  Any other business

Date of next meeting – 24th May 2016, Conference Rooms  4 & 5, Aviation House, 125 Kingsway, London WC2 6NH

 

Final Minutes